Pfizer Camptosar Paragraph IV Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with Paragraph IV certification for Pfizer's chemotherapy Camptosar was filed July 26, according to FDA's Oct. 1 updated list of Paragraph IV filings